©The Author(s) 2025.
World J Gastroenterol. Sep 14, 2025; 31(34): 109825
Published online Sep 14, 2025. doi: 10.3748/wjg.v31.i34.109825
Published online Sep 14, 2025. doi: 10.3748/wjg.v31.i34.109825
Figure 4 B-cell CLL/Lymphoma 10 affects cuproptosis sensitivity through DLAT regulation.
A: Quantitative PCR analysis of cuproptosis-related genes; B: Western blot of B-cell CLL/Lymphoma 10 (BCL10) and DLAT expression. aP < 0.05; bP < 0.01; C: TEM images of mitochondrial morphology (orange arrows: Damaged mitochondria with cristae disruption); D: Immunofluorescence of indicated proteins after elesclomol-Cu treatment; E: Non-reducing Western blot of DLAT oligomers; F and G: Flow cytometry after DLAT knockdown. cP < 0.001.
- Citation: Xiao PT, Li CF, Liu YD, Zhong J, Cui XL, Liu C, Yang W. B cell CLL/lymphoma 10 promotes colorectal cancer cell proliferation and regulates cuproptosis sensitivity through the NF-κB signaling pathway. World J Gastroenterol 2025; 31(34): 109825
- URL: https://www.wjgnet.com/1007-9327/full/v31/i34/109825.htm
- DOI: https://dx.doi.org/10.3748/wjg.v31.i34.109825